StocksFundsScreenerSectorsWatchlists
TDOC

TDOC - Teladoc Health Inc Stock Price, Fair Value and News

13.54USD-0.67 (-4.71%)Market Closed

Market Summary

TDOC
USD13.54-0.67
Market Closed
-4.71%

TDOC Alerts

  • 1 major insider sales recently.

TDOC Stock Price

View Fullscreen

TDOC RSI Chart

TDOC Valuation

Market Cap

2.3B

Price/Earnings (Trailing)

-10.26

Price/Sales (Trailing)

0.87

EV/EBITDA

22.85

Price/Free Cashflow

6.68

TDOC Price/Sales (Trailing)

TDOC Profitability

Operating Margin

95.05%

EBT Margin

-8.44%

Return on Equity

-9.47%

Return on Assets

-5.02%

Free Cashflow Yield

14.97%

TDOC Fundamentals

TDOC Revenue

Revenue (TTM)

2.6B

Rev. Growth (Yr)

3.58%

Rev. Growth (Qtr)

0.04%

TDOC Earnings

Earnings (TTM)

-220.4M

Earnings Growth (Yr)

99.24%

Earnings Growth (Qtr)

49.38%

Breaking Down TDOC Revenue

Last 7 days

-7.4%

Last 30 days

-10.4%

Last 90 days

-32.9%

Trailing 12 Months

-47.1%

How does TDOC drawdown profile look like?

TDOC Financial Health

Current Ratio

3.54

Debt/Equity

0.66

Debt/Cashflow

0.23

TDOC Investor Care

Shares Dilution (1Y)

2.72%

Diluted EPS (TTM)

-1.34

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20232.5B2.5B2.6B2.6B
20222.1B2.2B2.3B2.4B
20211.4B1.6B1.9B2.0B
2020605.5M716.3M867.1M1.1B
2019456.8M492.6M519.6M553.3M
2018280.0M330.0M372.3M417.9M
2017139.2M157.3M193.5M233.3M
201687.8M96.0M108.4M123.2M
201550.6M58.6M67.7M77.4M
2014027.8M35.7M43.5M
201300019.9M
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Teladoc Health Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Apr 02, 2024
nanis nikolaos p.
sold
-6,598
14.314
-461
chief technology officer
Apr 01, 2024
nanis nikolaos p.
acquired
-
-
1,232
chief technology officer
Mar 25, 2024
geshuri arnnon
sold
-112,950
15.06
-7,500
chief people officer
Mar 25, 2024
geshuri arnnon
acquired
20,475
2.73
7,500
chief people officer
Mar 18, 2024
trencher daniel
sold
-15,180
15.18
-1,000
chief strategy officer
Mar 05, 2024
turitz andrew
sold
-82,050
14.53
-5,647
evp, corporate development
Mar 04, 2024
verstraete stephany
sold
-115,330
14.516
-7,945
chief marketing officer
Mar 04, 2024
napolitano richard j
sold
-54,652
14.516
-3,765
chief accounting officer
Mar 04, 2024
kornwasser laizer
sold
-266,354
14.516
-18,349
president, enterprise growth
Mar 04, 2024
trencher daniel
sold
-98,418
14.516
-6,780
chief strategy officer

1–10 of 50

Which funds bought or sold TDOC recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Apr 12, 2024
Game Plan Financial Advisors, LLC
unchanged
-
-5,805
13,590
0.01%
Apr 12, 2024
Traynor Capital Management, Inc.
sold off
-100
-38,864
-
-%
Apr 12, 2024
IMC-Chicago, LLC
added
29.99
-70,863
723,879
-%
Apr 12, 2024
BALDWIN BROTHERS LLC/MA
unchanged
-
-18,447
43,186
-%
Apr 12, 2024
Pacifica Partners Inc.
unchanged
-
-206
904
-%
Apr 12, 2024
HARBOR INVESTMENT ADVISORY, LLC
reduced
-32.36
-14,012
12,624
-%
Apr 12, 2024
Ignite Planners, LLC
added
6.88
-75,421
197,608
0.06%
Apr 12, 2024
AdvisorNet Financial, Inc
added
1.66
-31,407
77,765
0.01%
Apr 11, 2024
Bangor Savings Bank
unchanged
-
-258
604
-%
Apr 11, 2024
Opal Wealth Advisors, LLC
new
-
1,948
1,948
-%

1–10 of 44

Are Funds Buying or Selling TDOC?

Are funds buying TDOC calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own TDOC
No. of Funds

Unveiling Teladoc Health Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2024
nikko asset management americas, inc.
4.50%
7,464,874
SC 13G/A
Feb 13, 2024
vanguard group inc
10.58%
17,514,904
SC 13G/A
Feb 05, 2024
sumitomo mitsui trust holdings, inc.
4.51%
7,474,674
SC 13G/A
Jan 29, 2024
ark investment management llc
12.82%
21,224,565
SC 13G/A
Jan 26, 2024
blackrock inc.
8.0%
13,203,121
SC 13G/A
Jul 10, 2023
vanguard group inc
10.58%
17,313,528
SC 13G/A
Feb 10, 2023
nikko asset management americas, inc.
5.01%
8,125,231
SC 13G/A
Feb 10, 2023
ark investment management llc
11.69%
18,928,440
SC 13G/A
Feb 09, 2023
vanguard group inc
8.94%
14,476,155
SC 13G/A
Feb 07, 2023
blackrock inc.
6.2%
9,961,219
SC 13G/A

Recent SEC filings of Teladoc Health Inc

View All Filings
Date Filed Form Type Document
Apr 12, 2024
8-K
Current Report
Apr 09, 2024
ARS
ARS
Apr 09, 2024
DEF 14A
DEF 14A
Apr 09, 2024
DEFA14A
DEFA14A
Apr 08, 2024
4
Insider Trading
Apr 05, 2024
8-K
Current Report
Apr 03, 2024
4
Insider Trading
Apr 02, 2024
144
Notice of Insider Sale Intent
Mar 26, 2024
4
Insider Trading
Mar 25, 2024
144
Notice of Insider Sale Intent

Peers (Alternatives to Teladoc Health Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
410.7B
371.6B
-9.23% -12.95%
18.35
1.11
14.64% 11.24%
102.0B
195.3B
-0.90% 34.65%
18.99
0.52
8.17% -20.79%
86.8B
357.8B
-10.90% -7.68%
10.39
0.24
10.95% 93.52%
85.3B
65.0B
0.18% 18.00%
16.28
1.31
7.86% -7.11%
38.9B
154.0B
-3.67% 6.80%
14.39
0.25
6.54% 124.79%
11.5B
14.3B
-4.30% 22.39%
16.07
0.81
6.59% 6.24%
11.4B
12.1B
-4.93% 54.73%
16.48
0.94
4.57% 23.40%
MID-CAP
9.3B
2.3B
-4.81% 9.59%
34.17
4.11
6.06% 9.17%
6.7B
2.9B
-6.00% -3.46%
-311.45
2.3
12.20% -107.93%
2.2B
1.4B
-1.50% 0.56%
35.86
1.57
21.19% 34.42%
2.2B
3.8B
-2.74% -34.13%
10.27
0.57
-27.73% -52.50%
SMALL-CAP
1.6B
1.1B
0.06% -12.91%
25.13
1.48
11.31% 35.83%
1.2B
3.0B
5.33% 55.67%
-6.33
0.4
6.74% 20.73%
48.4M
-
-23.65% -14.81%
-3.31
-
- -12.94%
18.2M
21.3M
11.67% 2.14%
34.08
0.85
8.00% -62.25%

Teladoc Health Inc News

Latest updates
MarketBeat12 hours ago
Yahoo Finance28 Mar 202407:00 am
InvestorPlace21 Feb 202408:00 am

Teladoc Health Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
Income Statement (Quarterly)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue0.0%660,527,000660,238,000652,406,000629,244,000637,709,000611,402,000592,379,000565,350,000554,235,000521,658,000503,139,000453,675,000383,321,000288,812,000241,030,000180,799,000156,489,000137,969,000130,276,000128,573,000122,741,000
Cost Of Revenue---------------------40,028,000
Gross Profit--------------------83,896,00082,713,000
Costs and Expenses-4.0%695,608,000724,963,000724,051,000706,346,0004,453,262,000683,132,0003,688,931,0007,234,729,000595,664,000582,234,000582,087,000538,353,000841,827,000308,537,000248,209,000201,810,000172,077,000157,913,000152,299,000151,460,000140,578,000
  S&GA Expenses2.2%53,451,00052,309,00053,530,00054,490,00056,279,00054,634,00057,930,00058,329,00059,330,00062,602,00063,856,00064,793,00093,942,00023,483,00018,687,00017,940,00016,751,00016,120,00015,832,00016,212,00014,509,000
  R&D Expenses6.7%89,938,00084,289,00087,309,00086,985,00082,931,00084,590,00078,696,00087,412,00072,867,00080,250,00080,759,00078,008,00092,697,00029,958,00023,029,00019,257,00016,246,00015,746,00016,665,00015,987,00013,544,000
EBITDA Margin103.2%0.05-1.42-1.48-2.75-5.58-4.17-4.36-3.17-0.13-0.37-0.42-0.46---------
Interest Expenses12.4%6,345,5005,646,0005,835,0003,648,00010,151,0006,149,0005,562,000-5,480,000142,634,000-18,895,000-20,473,000-22,125,000-21,100,500-16,970,000-13,262,000-8,618,000-7,581,000-7,700,000-7,211,000-6,521,000-6,663,000
Income Taxes241.5%3,515,000-2,484,000-952,000681,000-1,841,000-1,171,000-1,188,000388,000-49,721,5003,643,0003,196,00087,000,000-85,457,000-2,300,000-2,400,000-700,000-4,125,000-7,300,000100,000742,000379,000
Earnings Before Taxes57.4%-25,375,000-59,557,000-66,129,000-68,547,000-3,811,912,000-74,647,000-3,102,649,000-6,674,135,000-60,726,000-80,697,000-130,623,000-112,610,000-479,424,000-38,174,000-28,081,000-30,314,000-23,169,000-27,644,000-29,234,000-29,408,000-24,500,000
EBT Margin94.6%-0.08-1.55-1.59-2.86-5.68-4.27-4.44-3.24-0.19-0.43-0.47-0.48---------
Net Income49.4%-28,890,000-57,073,000-65,177,000-69,228,000-3,810,071,000-73,476,000-3,101,461,000-6,674,523,000-10,985,000-84,340,000-133,819,000-199,649,000-393,967,000-35,884,000-25,682,000-29,603,000-19,044,000-20,346,000-29,324,000-30,150,000-24,879,000
Net Income Margin94.5%-0.08-1.55-1.59-2.86-5.68-4.24-4.42-3.22-0.21-0.44-0.47-0.48---------
Free Cashflow28.9%128,678,00099,808,00099,278,00010,793,00059,354,00059,191,00089,927,000-35,660,00080,285,00075,385,00049,927,000-20,141,000---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets1.5%4,3924,3284,3164,3094,3458,1048,10311,09217,73517,65317,61117,58217,7553,4492,4191,6031,6031,5681,5651,5521,529
  Current Assets7.4%1,4891,3871,3211,2871,3151,2881,2571,2081,2251,1571,1051,0321,0601,3101,403596588558533541533
    Cash Equivalents9.0%1,1241,0319598899189008818368938247847207331,1871,309508514475440434424
  Inventory-17.8%30.0036.0034.0046.0056.0059.0060.0071.0073.0057.0057.0058.0056.0012.00-------
  Net PPE-2.6%32.0033.0030.0030.0030.0027.0027.0028.0027.0027.0028.0028.0029.0020.0010.0010.0010.0010.0010.0010.0010.00
  Goodwill0%1,0731,0731,0731,0731,0734,8464,8587,90014,50414,47014,45514,45214,5811,691900734746738748734737
  Current Liabilities4.5%42140338338140041137130733130227626033320112497.0090.0085.0070.0072.0062.00
  Long Term Debt0.1%1,5391,5381,5371,5361,5351,5341,5341,5331,2261,2111,2011,3531,380953948447440434427421415
    LT Debt, Current-------------43.00--------
    LT Debt, Non Current0.1%1,5391,5381,5371,5361,5351,5341,5341,5331,2261,2111,2011,3531,380953948447440434427421415
Shareholder's Equity1.4%2,3262,2942,2952,2912,3086,0536,0859,14316,04615,98816,00115,82915,8842,2311,2951,0001,0149941,0031,0021,013
  Retained Earnings-0.2%-15,228-15,199-15,142-15,077-15,008-11,198-11,124-8,023-1,421-1,410-1,326-1,192-992-598-562-537-507-488-468-438-408
  Additional Paid-In Capital0.3%17,59217,53517,47617,41017,35917,30017,23917,17717,47317,39917,31517,01716,8582,8351,8801,5721,5391,5101,4831,4571,435
Shares Outstanding0.7%167166165164163161161161157156154152---------
Float---4,145---5,334---26,317---14,937---4,607--
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations23.2%130,082105,601101,18213,15665,54963,02192,469-31,74783,20876,59152,217-18,026-114,93632,19535,550-6,32018,12213,4906,149-7,8922,476
  Share Based Compensation-11.6%46,82352,96455,72546,03850,75455,66251,00060,43661,61571,70182,97086,300414,38020,90821,92818,31518,45717,35417,36813,52312,683
Cashflow From Investing3.0%-36,506-37,647-36,570-45,624-53,891-41,448-44,837-27,567-20,075-34,708-2,168-16,030-413,925-155,460-9,662-11,9289,54713,194-5,0647,336-42,348
Cashflow From Financing-135.0%-1,7755,0684,2083,3534,381634-1,3342,8166,62578411,36322,17570,436422773,22515,05310,0419,1535,19810,7027,449

TDOC Income Statement

2023-12-31
Consolidated Statements of Operations and Other Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]   
Revenue$ 2,602,415$ 2,406,840$ 2,032,707
Expenses:   
Cost of revenue (exclusive of depreciation and amortization, which are shown separately below)760,031743,987650,258
Operating expenses:   
Advertising and marketing688,854623,536416,726
Sales213,780227,172250,581
Technology and development348,521333,629311,884
General and administrative464,659449,855438,007
Acquisition, integration, and transformation costs21,11015,62026,643
Restructuring costs16,9427,4160
Depreciation11,13811,4078,941
Amortization325,933244,620195,298
Goodwill impairment013,402,8120
Total expenses2,850,96816,060,0542,298,338
Loss from operations(248,553)(13,653,214)(265,631)
Loss on extinguishment of debt0043,748
Interest income(46,782)(12,674)(776)
Interest expense22,28221,94481,141
Other (income) expense, net(4,445)859(5,088)
Loss before provision for income taxes(219,608)(13,663,343)(384,656)
Provision for income taxes760(3,812)44,137
Net loss(220,368)(13,659,531)(428,793)
Other comprehensive income (loss), net of tax:   
Currency translation adjustment and other5,786(36,491)(24,803)
Comprehensive loss$ (214,582)$ (13,696,022)$ (453,596)
Net loss per share, basic (in dollars per share)$ (1.34)$ (84.60)$ (2.73)
Net loss per share, diluted (in dollars per share)$ (1.34)$ (84.60)$ (2.73)
Weighted-average shares used to compute basic net loss per share (in shares)164,578,219161,457,123156,939,349
Weighted-average shares used to compute diluted net loss per share (in shares)164,578,219161,457,123156,939,349

TDOC Balance Sheet

2023-12-31
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 1,123,675$ 918,182
Accounts receivable, net of allowance for doubtful accounts of $4,240 and $4,324 at December 31, 2023 and December 31, 2022, respectively217,423210,554
Inventories29,51356,342
Prepaid expenses and other current assets118,437130,310
Total current assets1,489,0481,315,388
Property and equipment, net32,03229,641
Goodwill1,073,1901,073,190
Intangible assets, net1,677,7811,836,765
Operating lease - right-of-use assets40,06041,831
Other assets80,25848,540
Total assets4,392,3694,345,355
Current liabilities:  
Accounts payable43,63747,690
Accrued expenses and other current liabilities178,634168,693
Accrued compensation102,68681,554
Deferred revenue-current95,659101,832
Total current liabilities420,616399,769
Other liabilities1,0801,618
Operating lease liabilities, net of current portion42,83738,042
Deferred revenue, net of current portion13,62311,954
Deferred taxes, net49,45250,939
Convertible senior notes, net1,538,6881,535,288
Commitments and contingencies (Note 17)
Stockholders’ equity:  
Common stock, $0.001 par value; 300,000,000 shares authorized; 166,658,253 shares and 162,840,360 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively167163
Additional paid-in capital17,591,55117,358,645
Accumulated deficit(15,228,655)(15,008,287)
Accumulated other comprehensive loss(36,990)(42,776)
Total stockholders’ equity2,326,0732,307,745
Total liabilities and stockholders’ equity$ 4,392,369$ 4,345,355
TDOC
Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company operates through two segments, Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its that licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.
 CEO
 WEBSITEteladochealth.com
 INDUSTRYHealthcare Plans
 EMPLOYEES4816

Teladoc Health Inc Frequently Asked Questions


What is the ticker symbol for Teladoc Health Inc? What does TDOC stand for in stocks?

TDOC is the stock ticker symbol of Teladoc Health Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Teladoc Health Inc (TDOC)?

As of Mon Apr 15 2024, market cap of Teladoc Health Inc is 2.26 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of TDOC stock?

You can check TDOC's fair value in chart for subscribers.

What is the fair value of TDOC stock?

You can check TDOC's fair value in chart for subscribers. The fair value of Teladoc Health Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Teladoc Health Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for TDOC so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Teladoc Health Inc a good stock to buy?

The fair value guage provides a quick view whether TDOC is over valued or under valued. Whether Teladoc Health Inc is cheap or expensive depends on the assumptions which impact Teladoc Health Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for TDOC.

What is Teladoc Health Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Mon Apr 15 2024, TDOC's PE ratio (Price to Earnings) is -10.26 and Price to Sales (PS) ratio is 0.87. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. TDOC PE ratio will change depending on the future growth rate expectations of investors.